SEC Form 4 · accession 0001638599-17-000662
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy A Springer
Director
Period of report
Jun 27, 2017
Accepted (ET)
Jun 28, 2017 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 27, 2017 | P | 338,791 | $17.71 | A | 355,413 | D | |
| Common StockF1,F2 | holding | — | — | — | 1,237,028 | I | See Footnotes | |
| Common StockF1,F3 | holding | — | — | — | 445,576 | I | See Footnotes |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy) | $17.71 | Jun 27, 2017 | P | 79,130 | A | Jun 27, 2017 | Jun 27, 2022 | Common Stock | 79,130 | 79,130 | D |
Explanation of responses
- F1LKST, Inc. is the general partner of Leukon. Timothy Springer is the president of LKST, Inc. and the managing member of TAS. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
- F2Held by Leukon Investments LP ("Leukon").
- F3Held by TAS Partners, LLC ("TAS").